Agilent Technologies (A) Cash from Financing Activities (2009 - 2026)
Agilent Technologies' (A) quarterly Cash from Financing Activities came in at $471.0 million in Q3 2026, up 315.07% year-over-year from $113.5 million in Q3 2025, and up 427.08% quarter-over-quarter from -$144.0 million in Q2 2026.
Analysis
Agilent Technologies (A) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Cash from Financing Activities for 18 consecutive years, with $471.0 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Cash from Financing Activities rose 315.07% year-over-year to $471.0 million in Q3 2026; TTM through Jul 2026 was -$95.0 million, a 80.61% increase from a year earlier, with the FY2025 full-year figure at -$715.0 million, up 4.92% from the prior year.
- Cash from Financing Activities was $471.0 million for Q3 2026 at Agilent Technologies, up from -$144.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $471.0 million in Q3 2026 and troughed at -$546.0 million in Q1 2022.
- A 5-year average of -$192.8 million and a median of -$219.0 million in 2025 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 1311.76% in 2024 and surged 315.07% in 2026, its largest moves.
- Over 5 years, Cash from Financing Activities stood at -$341.0 million in 2022, then soared by 41.06% to -$201.0 million in 2023, then surged by 112.44% to $25.0 million in 2024, then plunged by 900.0% to -$200.0 million in 2025, then soared by 335.5% to $471.0 million in 2026.
- The last three Cash from Financing Activities figures came in at $471.0 million (Q3 2026), -$144.0 million (Q2 2026), and -$222.0 million (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 471.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -129.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -23.16 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -33.21 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -27.60 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -6.20 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 3.02 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 149.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 471.00 Mn |
| Apr 30, 2026 | -144.00 Mn |
| Jan 31, 2026 | -222.00 Mn |
| Oct 31, 2025 | -200.00 Mn |
| Jul 31, 2025 | -219.00 Mn |
| Apr 30, 2025 | -116.00 Mn |
| Jan 31, 2025 | -180.00 Mn |
| Oct 31, 2024 | 25.00 Mn |
| Jul 31, 2024 | -246.00 Mn |
| Apr 30, 2024 | -291.00 Mn |
| Jan 31, 2024 | -240.00 Mn |
| Oct 31, 2023 | -201.00 Mn |
| Jul 31, 2023 | -322.00 Mn |
| Apr 30, 2023 | -390.00 Mn |
| Jan 31, 2023 | -17.00 Mn |
| Oct 31, 2022 | -341.00 Mn |
| Jul 31, 2022 | -362.00 Mn |
| Apr 30, 2022 | -123.00 Mn |
| Jan 31, 2022 | -546.00 Mn |
| Oct 31, 2021 | -324.00 Mn |